Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases

Cancer/Radiotherapie

Volumn 17, Issue 3, 2013, Pages 196-201

  Cutuli, B ^a   Lemanski, C ^b   Le Blanc Onfroy, M ^c   de Lafontan, B ^d   Cohen Solal Le Nir, C ^e   Fondrinier, E ^f   Mignotte, H ^g   Giard, S ^h   Charra Brunaud, C ⁱ   Auvray, H ^j   Gonzague Casabianca, L ^k   Quetin P ^l   Fay, R ^m  

^a Institut du Cancer Courlancy   (France)

^b CENTRE VAL D AURELLE   (France)

^c UMR INSERM U892 CNRS 6299   (France)

^d INSTITUT CLAUDIUS REGAUD   (France)

^e CENTRE RENÉ HUGUENIN   (France)

^f CENTRE PAUL PAPIN   (France)

^g CENTRE LÉON BÉRARD   (France)

^h CENTRE OSCAR LAMBRET   (France)

ⁱ CENTRE ALEXIS VAUTRIN   (France)

^j CENTRE JEAN PERRIN   (France)

^k INSTITUT PAOLI CALMETTES   (France)

^l CENTRE PAUL STRAUSS   (France)

^m Centre d'investigations cliniques   (France)

more..

Author keywords

Breast carcinoma; Breast conserving surgery; Ductal carcinoma in situ; Local recurrence; Metastases; Salvage treatment

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; LOCAL THERAPY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; SALVAGE THERAPY; TUMOR INVASION; ADJUVANT THERAPY; AXILLA; BREAST TUMOR; CARCINOMA IN SITU; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; RISK FACTOR; SEGMENTAL MASTECTOMY; STATISTICS; TUMOR RECURRENCE;

ADULT; AXILLA; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SALVAGE THERAPY;

EID: 84882940079     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2013.01.011     Document Type: Article

References (68)

1. Leonard G., Swain S.M. Ductal carcinoma in situ complexities and challenges. J Natl Cancer Inst 2004, 96:906-920.
2. Boyages J., Delaney G., Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ. A meta-analysis. Cancer 1999, 85:616-628.
3. Mokbel K., Cutuli B. Heterogeneity in DCIS and its effects on management. Lancet Oncol 2006, 7:756-765.
4. Lee L.A., Silverstein M.J., Chung C.T., Macdonald H., Sanghavi P., Epstein M., et al. Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma in situ of the breast. Am J Surg 2006, 192:416-419.
5. Cutuli B., Cohen-Solal-Le Nir C., de Lafontan B., Mignotte H., Fichet V., Fay R., et al. Breast conserving therapy for ductal carcinoma in situ of the breast: the French Cancer centres' experience. Int J Radiat Oncol Biol Phys 2002, 53:868-879.
6. Perez C.A., Taylor M.E., Aft R., Doherty G.M., Levy J., Young G. Ductal carcinoma in situ: management of breast relapses after initial treatment. Semin Breast Dis 2000, 3:239-247.
7. Solin L.J., Fourquet A., Vicini F., Haffty B., Taylor M., Mc Cormick B., et al. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Cancer 2001, 91:1090-1097.
8. Solin L., Fourquet A., Vicini F., Taylor M., Olivotto I.A., Haffty B., et al. Long-term outcome after breast conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 2005, 103:1137-1146.
9. Fisher B., Dignam J., Wolmark N., Mamounas E., Costantino J., Poller W., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998, 16:441-452.
10. Silverstein M.J., Wisman J.R. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. Ductal carcinoma in situ of the breast 2002, 545-553. Lippincott William and Wilkins, Philadelphia. 2nd ed. M.J. Silverstein, A. Recht, M. Lagios (Eds.).
11. Cutuli B., Cohen-Solal Le Nir C., De Lafontan B., Mignotte H., Fichet V., Fay R., et al. Ductal carcinoma in situ of the breast. Results of conservative and radical treatments in 716 patients. Eur J Cancer 2001, 37:2365-2372.
12. Schnitt S.J. Local outcome in ductal carcinoma in situ based on patient and tumour characteristics. J Natl Cancer Inst Monogr 2010, 41:158-161.
13. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Overview of the randomized trial of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010, 41:162-177.
14. Solin L. The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010, 41:187-192.
15. Romero L., Klein L., Ye W., Holmes D., Soni R., Silbermann H., et al. Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast. Am J Surg 2004, 188:371-376.
16. Solin L., Fourquet A., Vicini F., Taylor M., Haffty B., Strom E.A., et al. Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. Eur J Cancer 2005, 41:1715-1723.
17. Fisher B., Land S., Mamounas E., Dignam J., Fisher E.R., Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience. Semin Oncol 2001, 28:400-418.
18. Wapnir I.L., Dignam J.J., Fisher B., Mamounas E.P., Anderson S.J., Julian T.B., et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011, 103:478-488.
19. Bijker N., Meijnen P., Peterse J.L., Bogaerts J., Van Hoorebeeck I., Julien J.P., et al. Breast conserving treatment with or without RT in ductal carcinoma in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853. A study by the EORTC Breast Cancer Co-operative group and EORTC Radiotherapy group. J Clin Oncol 2006, 24:3381-3387.
20. Houghton J., George W.D., Cuzick J., Duggan C., Fentiman I.S., Spittle M. Radiotherapy and Tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003, 362:95-102.
21. Holmberg L., Garmo H., Granstrand B., Ringberg A., Arnesson L.G., Sandelin K., et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 2008, 26:1247-1252.
22. Pinder S.E., Duggan C., Ellis I.O., Cuzick J., Forbes J.F., Bishop H., et al. A new pathological system for grading DCIS with improved prediction of local recurrence results from the UKCCCR/ANZ DCIS trial. Br J Cancer 2010, 103:94-100.
23. Cuzick J., Sestak I., Pinder S.E., Ellis I.O., Forsyth S., Bundred N.J., et al. Effect of Tamoxifen and radiotherapy in women wth locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011, 1:21-29.
24. Warren J.L., Weaver D.L., Bocklage T., Key C.R., Platz C.E., Cronin K.A., et al. The frequency of ipsilateral second tumours after breast-conserving surgery for DCIS. A population-based analysis. Cancer 2005, 104:1840-1848.
25. Vicini F.A., Kestin L.L., Goldstein N.S., Chen P.Y., Pettinga J., Frazier R.C., et al. Impact of young age on outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy. J Clin Oncol 2000, 18:296-306.
26. Smith G.L., Smith B.D., Haffty B.G. Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 2006, 65:1397-1403.
27. Schouten Van Der Velden A.P., Peeters P.H., Koot V.S., Hennipman A. Local recurrences after conservative treatment of ductal carcinoma in situ of the breast without radiotherapy: the effect of age. Ann Surg Oncol 2006, 13:990-998.
28. Rakovitch E., Pignol J.P., Hanna W., Narod S., Spayne J., Nofech-Mozes S., et al. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy. J Clin Oncol 2007, 25:5591-5596.
29. Meijnen P., Oldenburg H.S., Peterse J.L., Bartelink H., Rutgers E.J. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Ann Surg Oncol 2008, 15:235-243.
30. Van Zee K.J., Liberman L., Samli B., Tran K.N., Mc Cormick B., Petrek J.A., et al. Long-term follow-up of women with ductal carcinoma in situ treated with breast conserving surgery. The effect of age. Cancer 1999, 86:1757-1767.
31. Vicini F.A., Recht A. Age at diagnosis and outcome for women with ductal carcinoma in situ of the breast: a critical review of the literature. J Clin Oncol 2002, 20:2736-2744.
32. Guerrieri-Gonzaga A., Botteri E., Rotmensz N., Bassi F., Intra M., Serrano D., et al. Ductal intraepithelial neoplasia: post-surgical outcome for 1267 women cared in one single institution over 10years. Oncologist 2009, 14:201-212.
33. Mac Donald H.R., Silverstein M.J., Mabry H., Moorthy B., Ye W., Epstein M.S., et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg 2005, 190:521-525.
34. Vargas C., Kestin L., Go N., Krauss D., Chen P., Goldstein N., et al. Factors associated with local recurrence and cause specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys 2005, 63:1514-1521.
35. Dunne C., Burke J.P., Morrow M., Kell M.R. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009, 27:1615-1620.
36. Rudloff U., Jacks L.M., Goldberg J.I., Wynveen C.A., Brogi E., Patil S., et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 2010, 28:3762-3769.
37. Yi M., Meric-Bernstam F., Kuerer H.M., Mittendorf E.A., Bedrosian I., Lucci A., et al. Evaluation of a breast cancer mammogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 2012, 30:600-607.
38. Punglia R.S., Burstein H.J., Weeks J.C. Radiation therapy for ductal carcinoma in situ: a decision analysis. Cancer 2012, 118:603-611.
39. Kerlikowske K., Molinaro A.M., Gauthier M.L., Berman H.K., Waldman F., Bennington J., et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 2010, 102:627-637.
40. Cutuli B., Lemanski C., Fourquet A., De Lafontan B., Giard S., Meunier A., et al. Breast conserving surgery with or without radiotherapy versus mastectomy for ductal carcinoma in situ: French survey experience. Br J Cancer 2009, 100:1048-1054.
41. Allegra C.J., Aberle D.R., Ganshow P., Hahn S.M., Lee C.N., Million-Underwood S., et al. National institute of health state of science conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J Natl Cancer Inst 2010, 102:161-169.
42. Bonnier P., Body G., Bessenay F., Charpin C., Fetissof F., Beedassy B., et al. Prognostic factors in ductal carcinoma in situ of the breast: results of a retrospective study of 575 cases. Eur J Obstet Gynecol 1999, 84:27-35.
43. Fisher B. Highlights from recent national surgical adjuvant breast and bowel project studies in the treatment and prevention of breast cancer. Cancer J Clin 1999, 49:159-177.
44. Silverstein M.J. The Van Nuys/USC experience by treatment. Ductal carcinoma in situ of the breast 2002, 337-342. Lippincott William and Wilkins, Philadelphia. 2nd ed. M.J. Silverstein, A. Recht, M. Lagios (Eds.).
45. Tunon de Lara C., Lemanski C., Cohen-Solal Le-Nir C., de Lafontan B., Charra-Brunaud C., Gonzague-Casabianca L., et al. Ductal carcinoma in situ of the breast in young women: a subgroup of patients at high risk with lower survival. Eur J Surg Oncol 2011, 18:1372-1379.
46. Shaitelman S.F., Wilkinson J.B., Kestin L.L., Ye H., Goldstein N.S., Martinez A., et al. Long-term outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy: implications for optimal follow-up strategies. Int J Radiat Oncol Biol Phys 2012, 83:e305-e312.
47. Buist D.S., Abraham L.A., Barlow W.E. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat 2010, 124:863-873.
48. Habel L.A., Archaroso N.S., Haque R., Nekhlyudov L., Fletcher S.W., Schnitt S.J., et al. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res 2009, 11:R85.
49. Halasz L.M., Sreedhara M., Chen Y.H., Bellon J.R., Punglia R.S., Wong J., et al. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 2012, 82:e581-e586.
50. Kane R.L., Virnig B.A., Shamliyan T., Wang S.Y., Tuttle T.M., Witt T.J., et al. The impact of surgery, radiation and systemic treatment on outcomes in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010, 41:130-133.
51. Eng Wong J., Costantino J.P., Swain S.M. The impact of systemic therapy following ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010, 41:200-203.
52. Guerrieri-Gonzaga A., Botteri E., Lazzeroni M., Rotmensz N., Goldhirsh A., Varricchio C., et al. Low-dose Tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study. Ann Oncol 2010, 21:949-954.
53. Allred D.C., Anderson S.J., Paik S., Wickerham L., Nagtegaal I.D., Swain S.M., et al. Adjuvant Tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol 2012, 30:1268-1273.
54. Decensi A., Pruneri G., Guerrieri-Gonzaga A. Estrogens receptor in breast ductal carcinoma in situ: good cap, bad cap?. J Clin Oncol 2012, 30:1384-1386.
55. Morrow M. Refining the use of endocrine therapy for ductal carcinoma in situ. J Clin Oncol 2012, 30:1249-1251.
56. Solin L.J. The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010, 41:187-192.
57. Pinski R.W., Rebner M., Pierce L.J., Ben-David M.A., Vicini F., Hunt K., et al. Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection and stage of recurrence. Am J Radiol 2007, 189:140-144.
58. Lehman C.D. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010, 41:150-151.
59. Cutuli B. La radiothérapie des cancers du sein en 2012 : quelles stratégies ?. Cancer Radiother 2012, 16:493-502.
60. Wang S.Y., Shamliyan T., Jalal H., Kuntz K.M., Kane R.L., Virnig B.A. Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst 2012, 104:507-516.
61. Omlin A., Amichetti M., Azria D., Cole B.F., Fourneret P., Poortmans P., et al. Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 2006, 7:652-656.
62. Wong P., Lambert C., Agnihotram R.V., David M., Duclos M., Freeman C.R. Ductal carcinoma in situ. The influence of the radiotherapy boost on local control. Int J Radiat Oncol Biol Phys 2012, 82:e153-e158.
63. Hughes L.L., Wang M., Page D.L., Gray R., Solin L., Davidson N.E., et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial for the Eastern Cooperative Oncology Group. J Clin Oncol 2009, 27:5319-5324.
64. Romestaing P. Cancers canalaires in situ de moins de 5mm : pas de radiothérapie postopératoire. Gynecol Obstet Fertil 2012, 40:387-389.
65. Solin L.J. Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: the search continues. J Clin Oncol 2012, 30:577-579.
66. Motwani S.B., Goyal S., Moran M.S., Chhabra A., Haffty B.G. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194. Cancer 2011, 117:1156-1162.
67. Cutuli B. Cancers canalaires in situ de moins de 5mm : pour la radiothérapie postopératoire. Gynecol Obstet Fertil 2012, 40:384-386.
68. Collins L.C., Achacoso N., Nekhlyodov L., Fletcher S.W., Haque R., Quesenberry C.D., et al. Relationship between clinical and pathological features of ductal carcinoma in situ and patient age: an analysis of 657 cases. Am J Surg Pathol 2009, 33:1802-1808.